Across Europe, Clostridium difficile infection (CDI) ranks among the top 10 most common healthcare acquired infections (HAIs) [1] . CDI accounts for approximately 50% of gastrointestinal infections which in turn represent about 8% of all HAIs [1] . In the last decade, many European countries have reported rising rates of CDI, as well as more severe and recurrent disease [2, 3, 4, 5] .
The age distribution are similiar for patients with CDI in Denmark, Norway and Sweden (Figure 2 ). The majority of patients are above 75 years and about 1 out of four patients are 85 years or older. In Norway 27% are below 65 years while only 21% are below 65 years in Denmark and Sweden. In Denmark 43% of the patients were men and in Sweden 45% of the patients were men. (No available data from Finland regarding age and gender, no gender data from Norway.) [7, 8, 9] 
Length of stay (LOS)
The mean LOS for patients with CDI as primary diagnosis varied from 7.0 days in Norway to 14.7 days in Finland ( Figure 3 [6, 7, 8, 9] The mean LOS for patient with CDI as primary diagnosis increases with age and the pattern is similar in all three countries (no available data for Finland) (Figure 4 ). The LOS is approximately twice as high in the older age-groups (75+) compared to the youngest age-groups (0-24). [7, 8, 9] 
Cost of treating CDI
The total cost of treating hospitalised CDI patients varies between the countries due to differences in population size, number of hospitalisations, average LOS and cost per bed-day (Table 1) . Norway with the smallest population had the lowest total cost (€ 6 million) for CDI but also the lowest cost per CDI hospitalisation (€ 4,100), attributable to having shortest average LOS, lowest cost per bed day, and lowest number of CDI cases. Finland had the highest cost per hospitalisation (€ 8,800) mainly due to the longest average LOS. Sweden had the highest total cost for CDI (€ 30 million) due to the highest number of CDI cases which in turn corresponds to the size of the population. Denmark had a higher cost per hospitalisation than both Sweden and Norway, but lower compared to Finland. Taking the population size into account, Finland had the highest total cost for treating hospitalised CDI patients during one year. [6, 7, 8, 9] [9, 10, 11, 12] .
CONCLUSION
The total cost of treating the CDI patients ranges between €6-30 million per country per year, and approximately 26-38% of these costs are attributable to recurrence of CDI. By lowering the number of recurrences, there would be a potential for large cost savings by hospitals in Nordic countries. Number of days
